How to work with us
Hookipa is dedicated to utilizing the full potential of its two product platforms Vaxwave® and TheraT®. Vaxwave® is focused on the development of prophylactic vaccines to prevent infectious diseases and TheraT® enables Hookipa to develop immuno-oncology therapies and therapeutic vaccines.
We have forged a partnership with Gilead to Develop Immunotherapies against HIV and Hepatitis B. All related information can be found in this Press Release. We are open for further strategic partnerships which reflect the potential of the technology, provide performance related downstream revenues while preserving growth opportunities for Hookipa in the future.
Please contact our Senior Vice President Business Development & Licensing Torsten Mummenbrauer with any inquiries.
We look forward to hearing from you!